Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07232134
What this trial is testing

The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia

Who this might be right for
AML (Acute Myelogenous Leukemia)Down Syndrome (DS)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100
Not applicableStudy completedNCT01356134
What this trial is testing

Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI)

Who this might be right for
Ehlers-Danlos SyndromeMultiple Sclerosis
Genetic Disease Investigators 60
Not applicableStudy completedNCT04126499
What this trial is testing

Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain

Who this might be right for
Severe Eosinophilic Asthma
AstraZeneca 28
Early research (Phase 1)Ended earlyNCT03126864
What this trial is testing

Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia

Who this might be right for
Hematopoietic/Lymphoid CancerAcute Myeloid Leukemia
M.D. Anderson Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT03901963
What this trial is testing

Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 200
Not applicableStudy completedNCT04628234
What this trial is testing

Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT)

Who this might be right for
Hematologic MalignancyTumor, Solid
Institut de cancérologie Strasbourg Europe 53
Testing effectiveness (Phase 2)Study completedNCT00762632
What this trial is testing

Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Technical University of Munich 40
Early research (Phase 1)Study completedNCT02920398
What this trial is testing

A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 21
Testing effectiveness (Phase 2)Looking for participantsNCT06514534
What this trial is testing

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

Who this might be right for
Chronic Myeloid Leukemia (CML)
Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Study completedNCT01146834
What this trial is testing

Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 47
Early research (Phase 1)Study completedNCT01671904
What this trial is testing

Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Genentech, Inc. 84
Testing effectiveness (Phase 2)Study completedNCT01098084
What this trial is testing

Decitabine in Patients With Chronic Myelomonocytic Leukemia (CMML)

Who this might be right for
Chronic Myelomonocytic Leukemia
Groupe Francophone des Myelodysplasies 41
Large-scale testing (Phase 3)Study completedNCT01460693
What this trial is testing

Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia

Who this might be right for
Myeloid Leukemia, Chronic, Chronic Phase
Newcastle University 814
Testing effectiveness (Phase 2)Ended earlyNCT01548573
What this trial is testing

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

Who this might be right for
Multiple Myeloma
University of Iowa 19
Post-approval studies (Phase 4)WithdrawnNCT02926651
What this trial is testing

Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty

Who this might be right for
AnemiaArthritisTotal Knee Arthroplasty+1 more
Rush University Medical Center
Not applicableEnded earlyNCT05833737
What this trial is testing

Corneal Findings in Patients Treated With Belantamab Mafodotin

Who this might be right for
Multiple MyelomaCorneal DiseasesCorneal Cyst
Medical University of Vienna 12
Testing effectiveness (Phase 2)Study completedNCT01700673
What this trial is testing

Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03512405
What this trial is testing

Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
CD19 PositivePhiladelphia Chromosome PositiveRecurrent Acute Lymphoblastic Leukemia+1 more
City of Hope Medical Center 36
Not applicableNot Yet RecruitingNCT07179094
What this trial is testing

The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash

Who this might be right for
Hematologic NeoplasmsNauseaVomiting+1 more
Şule Güzle 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04656951
What this trial is testing

Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse

Who this might be right for
Multiple Myeloma
University of Cologne 67
Next Page